학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 2,392건 | 목록 1~20
Academic Journal
Thomassen D; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Roychoudhury S; Pfizer Inc, New York, NY, USA.; Amdal CD; Research Support Services, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Reynders D; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.; Musoro JZ; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Sauerbrei W; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany.; Goetghebeur E; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.; le Cessie S; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands. s.le_cessie@lumc.nl.; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium. s.le_cessie@lumc.nl.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. s.le_cessie@lumc.nl.
Publisher: BioMed Central Country of Publication: England NLM ID: 100968545 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2288 (Electronic) Linking ISSN: 14712288 NLM ISO Abbreviation: BMC Med Res Methodol Subsets: MEDLINE
Academic Journal
Amdal CD; Oslo University Hospital, Oslo, Norway.; Falk RS; Oslo University Hospital, Oslo, Norway.; Alanya A; Quality of Life Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Schlichting M; Merck, Healthcare KGaA, Darmstadt, Germany.; Roychoudhury S; Pfizer, New York, NY, USA.; Bhatnagar V; US Food and Drug Administration, Silver Spring, MD, USA.; Wintner LM; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.; Regnault A; Modus Outcomes, Lyon, France.; Ingelgård A; Boehringer Ingelheim, Ingelheim am Rhein, Germany.; Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; le Cessie S; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands.; Holzner B; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.; Chang J; Pfizer, New York, NY, USA.; Taphoorn M; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.; Cislo P; Pfizer, New York, NY, USA.; Giesinger JM; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.; Cappelleri JC; Pfizer, New York, NY, USA.; Pawar V; EMD Serono, Billerica, MA, USA.; Ten Seldam S; Myeloma Patients Europe, Brussels, Belgium.; Papadopoulos EJ; AbbVie, Mettawa, IL, USA.; Calvert MJ; Centre for Patient Reported Outcomes Research and NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.; Joseph KL; Oslo University Hospital, Oslo, Norway.; Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Griebsch I; Boehringer Ingelheim, Ingelheim am Rhein, Germany.; Arraras JI; Hospital Universitario de Navarra, Pamplona, Spain.; Astrup GL; Oslo University Hospital, Oslo, Norway.; Basch E; American Society for Clinical Oncology, Alexandria, VA, USA.; Belančić A; Clinical Hospital Center Rijeka, Rijeka, Croatia.; Brundage M; Queen's University at Kingston, Kingston, ON, Canada.; Campbell A; Patient Relevant Evidence, San Francisco, CA, USA.; Rerhou Rantell K; Medicines and Healthcare products Regulatory Agency, London, UK.; Cocks K; Adelphi Values, Bollington, UK.; Cherny N; European Society for Medical Oncology, Lugano, Switzerland.; Eremenco S; Critical Path Institute, Tucson, AZ, USA.; Ferrer M; Hospital del Mar Research Institute, Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Barcelona, Spain.; Fiero MH; US Food and Drug Administration, Silver Spring, MD, USA.; Gerlinger C; Bayer AG, Berlin, Germany; Gynaecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, Homburg, Germany.; Goetghebeur E; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.; Grouven U; Institute for Quality and Efficiency in Health Care, Cologne, Germany.; Lauer A; Boehringer Ingelheim, Ingelheim am Rhein, Germany.; Aiyegbusi OL; Centre for Patient Reported Outcomes Research and NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.; Machingura A; Quality of Life Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Mizusawa J; Japan Clinical Oncology Group, National Cancer Center Hospital, Tokyo, Japan.; Molenberghs G; KU Leuven, Leuven, Belgium; Hasselt University, Hasselt, Belgium.; Aa Petersen M; Region Hovedstaden, Copenhagen, Denmark.; Reijneveld JC; Amsterdam University Medical Center, Amsterdam, Netherlands.; Ringash J; University Health Network, Toronto, ON, Canada.; Rumpold G; Evaluation Software Development, Innsbruck, Austria.; Rutherford C; Faculty of Medicine and Health and Susan Wakil School of Nursing and Midwifery, Sydney Quality of Life Office, University of Sydney, Sydney, NSW, Australia.; Quinten C; European Medicines Agency, Amsterdam, Netherlands.; Sail K; AbbVie, Mettawa, IL, USA.; Sasseville M; Health Canada, Ottawa, ON, Canada.; Sauerbrei W; Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.; Schiel A; Norwegian Medical Products Agency, Oslo, Norway.; Smith AW; National Cancer Institute, Bethesda, MD, USA.; Snyder C; Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Velikova G; Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Leeds Cancer Centre, St James's Hospital, Leeds, UK.; Wang XS; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bjordal K; Oslo University Hospital, Oslo, Norway.; Pe M; Quality of Life Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. Electronic address: madeline.pe@eortc.org.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Cessie, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어